About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Drug Information Journal
›
Top Articles
Drug Information Journal
0.5
(top 100%)
impact factor
2.5K
(top 10%)
papers
17.7K
(top 10%)
citations
47
(top 20%)
h
-index
0.6
(top 100%)
impact factor
3.5K
all documents
18.5K
doc citations
81
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
VigiBase, the WHO Global ICSR Database System: Basic Facts
Drug Information Journal
2008
398
2
The Use of Biological Assays to Evaluate Botanicals
Drug Information Journal
1998
382
3
Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process
Drug Information Journal
2002
306
4
Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party
Drug Information Journal
1995
232
5
The Application of the Principle of Intention–to–Treat to the Analysis of Clinical Trials
Drug Information Journal
1991
206
6
Type I Error Rates from Mixed Effects Model Repeated Measures Versus Fixed Effects Anova with Missing Values Imputed Via Last Observation Carried Forward
Drug Information Journal
2001
129
7
The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview
Drug Information Journal
2003
118
8
Adaptive Seamless Phase II/III Designs—Background, Operational Aspects, and Examples
Drug Information Journal
2006
114
9
Adaptive Designs: Terminology and Classification
Drug Information Journal
2006
114
10
Statistical Considerations for Multiplicity in Confirmatory Protocols
Drug Information Journal
1996
97
11
Quality Criteria and Standardization of Phytopharmaceuticals: Can Acceptable Drug Standards Be Achieved?
Drug Information Journal
1998
94
12
Government Viewpoint of Clinical Trials
Drug Information Journal
1982
90
13
R&D Costs and Returns by Therapeutic Category
Drug Information Journal
2004
85
14
Use of Fingerprinting and Marker Compounds for Identification and Standardization of Botanical Drugs: Strategies for Applying Pharmaceutical HPLC Analysis to Herbal Products
Drug Information Journal
1998
84
15
Guidelines for Economic Evaluations in Italy: Recommendations from The Italian Group of Pharmacoeconomic Studies
Drug Information Journal
2001
84
16
Evaluation of Indian Traditional Medicine
Drug Information Journal
2001
81
17
Some Issues in the Design and Analysis of Equivalence Trials
Drug Information Journal
1999
80
18
Sample Size Reestimation: A Review and Recommendations
Drug Information Journal
2006
78
19
Handling Missing Data in Clinical Trials: An Overview
Drug Information Journal
2000
77
20
Statistical Assessment of Mean Differences between Two Dissolution Data Sets
Drug Information Journal
1996
75
21
Intent-to-Treat Analysis versus As-Treated Analysis
Drug Information Journal
1996
73
22
Flexible Sample Size Considerations Using Information-Based Interim Monitoring
Drug Information Journal
2001
70
23
Innovation Deficit in the Pharmaceutical Industry
Drug Information Journal
1996
67
24
Design Issues in Noninferiority/Equivalence Trials
Drug Information Journal
1999
67
25
Effective Strategies for Maintaining Research Participation in Clinical Trials
Drug Information Journal
2009
62
26
Implementing Adaptive Designs: Logistical and Operational Considerations
Drug Information Journal
2006
60
27
In Vitro/In Vivo Correlations
Drug Information Journal
1995
58
28
Risk Perception of Prescription Drugs: Results of a National Survey
Drug Information Journal
2007
57
29
Assessment of Consistency of Treatment Effects in Multiregional Clinical Trials
Drug Information Journal
2010
56
30
A Quantitative Approach for Making Go/No-Go Decisions in Drug Development
Drug Information Journal
2011
53
31
On the Use of the Accelerated Failure Time Model As An Alternative to the Proportional Hazards Model in the Treatment of Time to Event Data: A Case Study in Influenza
Drug Information Journal
2002
52
32
Public Health Care Management of Water Pollution with Pharmaceuticals: Environmental Classification and Analysis of Pharmaceutical Residues in Sewage Water
Drug Information Journal
2005
52
33
New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms
Drug Information Journal
2000
51
34
Using Conjoint Analysis to Evaluate Health State Preferences
Drug Information Journal
1999
50
35
Interim Monitoring of Group Sequential Trials Using Spending Functions for the Type I and Type II Error Probabilities
Drug Information Journal
2001
50
36
Adaptive Dose-Response Studies
Drug Information Journal
2006
50
37
International Harmonization and Consensus DIA Meeting on Bioavailability and Bioequivalence Testing Requirements and Standards
Drug Information Journal
1991
48
38
Measuring the Incidence, Causes, and Repercussions of Protocol Amendments
Drug Information Journal
2011
48
39
Cross-Cultural Comparability of Quality of Life Measures
Drug Information Journal
1993
46
40
Nonparametric Analysis of Covariance and Its Role in Noninferiority Clinical Trials
Drug Information Journal
1999
46
41
Some Developments on the International Index of Erectile Function (IIEF)
Drug Information Journal
1999
45
42
Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team
Drug Information Journal
2005
45
43
Confidentiality and Trial Integrity Issues for Adaptive Designs
Drug Information Journal
2006
45
44
Consequences of Delayed Treatment Effects on Analysis of Time-to-Event Endpoints
Drug Information Journal
2007
44
45
Impact of Unrecognized Dosing Errors on the Cost and Effectiveness of Pharmaceuticals
Drug Information Journal
1988
42
46
Summarizing Laboratory Data with Different Reference Ranges in Multi-Center Clinical Trials
Drug Information Journal
1992
42
47
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs
Drug Information Journal
2012
41
48
The International Register of Lithium Babies
Drug Information Journal
1976
40
49
Population Pharmacokinetics and Pharmacodynamics: An Underutilized Resource
Drug Information Journal
1998
40
50
One Large, Well-Designed, Multicenter Study as an Alternative to the Usual Fda Paradigm
Drug Information Journal
1999
39
site/software ©
exaly
; All materials licenced under
CC by-SA
.